Brief: Rovi FY EBITDA 216.2 Mln Euros

Laboratorios Farmaceuticos Rovi

25/02/2026 06:43

Feb 25 (Reuters) - Laboratorios Farmaceuticos ROVI SA ROVI.MC:

FY EBITDA 216.2 MILLION EUROS VERSUS 197.7 MILLION EUROS LSEG ESTIMATE

Source text: nCNMbTPrvB

Further company coverage: ROVI.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com;))